Ignite Creation Date:
2024-05-05 @ 10:10 PM
Last Modification Date:
2024-10-26 @ 10:14 AM
Study NCT ID:
NCT01040936
Status:
UNKNOWN
Last Update Posted:
2011-06-15
First Post:
2009-12-29
Brief Title:
Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome NSTE-ACS Patients
Sponsor:
Shanghai Jiao Tong University School of Medicine
Organization:
Shanghai Jiao Tong University School of Medicine
Study Overview
Official Title:
Intensive Lipid Lowering Treatment in Patients With Non-ST-elevation ACS Undergoing Percutaneous Coronary Intervention
Status:
UNKNOWN
Status Verified Date:
2011-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ILLEPE-ACS
Brief Summary:
PCI has been one of the most common choice of treatments for patients with coronary artery disease and studies indicated that intensive statin treatment before PCI could reduce adverse events as comparing to the placebo In China statin with regular dose is currently applied to the patients admitted for Non-ST-elevation acute coronary syndrome ACS Here we hypothesize that intensive statin treatment with arovastatin before PCI could further reduce clinical adverse events
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RJH-2009 | OTHER | RuiJin Hospital Shanghai Jiaotong University School of Medicine | None |